From Flow Modulation to Resection: First in Human Combination of Liver Venous Deprivation and Balloon-Occluded Chemoembolization (LVD-B-TACE): A Case Report Demonstrating a Novel Sequential Concept [0.03%]
从血流调节到规则性切除：首例联合应用肝脏瘤静脉剥夺和导管超选择介入灌注术（LVBP-TAE）的临床病例报告及新型序贯疗法的概念验证
Tomas Tuma,Jiri Pudil,Tomas Koutny et al.
Tomas Tuma et al.
Curative surgical treatment of hepatocellular carcinoma (HCC) is limited to liver transplantation (LT) and liver resection (LR), but many patients are ineligible due to insufficient future liver remnant (FLR). Liver venous deprivation (LVD)...
Early Recurrent Hepatocellular Carcinoma with CK19 Positive Receiving Transarterial Chemoembolization After Surgical Resection: A Novel Risk Model Study [0.03%]
术后TACE治疗的早期复发肝细胞癌伴CK19阳性患者的新型风险模型研究
Di Zhu,Wei Yang,Hai-Feng Zhou et al.
Di Zhu et al.
Objective: To evaluate the benefit of nomogram-based model for predicting response and survival in patients with early recurrent hepatocellular carcinoma after hepatic resection by CK19 positive expression treated with tr...
Extent of Embolization as an Independent Prognostic Factor in Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma [0.03%]
超选择性常规肝动脉化疗栓塞治疗肝细胞癌疗效的栓塞范围独立预后因素作用分析
Kenichiro Okumura,Takahiro Ogi,Junichi Matsumoto et al.
Kenichiro Okumura et al.
Purpose: Superselective conventional transarterial chemoembolization (ss‑cTACE) guided by angiography-multidetector CT (AMDCT) improves feeder detection but can broaden the treated territory and compromise hepatic reserv...
Multicenter Validation of a RAR-Based Nomogram for Predicting Postoperative Progression in HBV-Related Hepatocellular Carcinoma [0.03%]
一项基于RAR的列线图预测乙型肝炎相关性肝癌术后进展的多中心验证研究
Wei Dai,Maoqing Tan,Wenlong Shen et al.
Wei Dai et al.
Background: The red cell distribution width-to-albumin ratio (RAR) is a biomarker reflecting systemic inflammation and oxidative stress, and has been associated with outcomes in multiple diseases. However, its value for p...
Gustave Roussy Immune Score Predicts Outcomes in Hepatocellular Carcinoma Treated with TACE and Immunotherapy [0.03%]
Gustave Roussy免疫评分可预测经TACE和免疫治疗的肝细胞癌患者的预后
Lihao Qin,Xiao-Yang Xu,Hao Yang et al.
Lihao Qin et al.
Objective: To evaluate the prognostic value of the Gustave Roussy Immune (GRIm) score and the hepatocellular carcinoma-specific GRIm (HCC-GRIm) score in unresectable hepatocellular carcinoma (uHCC) treated with transarter...
Plasma Sphingolipid Profiling Predicts Radiosensitivity in Hepatocellular Carcinoma [0.03%]
血浆鞘脂谱预测肝细胞癌的放射敏感性
Xiang Yuan,Kai Wang,Fengxin Chen et al.
Xiang Yuan et al.
Purpose: Radiotherapy constitutes a cornerstone in the management of hepatocellular carcinoma (HCC), but its efficacy is limited by radioresistance. Sphingolipids, a class of bioactive lipids, have been implicated in the ...
Thrombomodulin Mitigates the Progression of Hepatocellular Carcinoma in Steatotic Liver [0.03%]
血管内皮细胞蛋白C受体及血栓调节蛋白在肝硬化和非酒精性脂肪性肝病中的作用及其机制研究
Megumi Yamaguchi,Hirotaka Tashiro,Shintaro Kuroda et al.
Megumi Yamaguchi et al.
Introduction: Metabolic dysfunction associated steatotic liver disease promotes intrahepatic metastasis of liver cancer, although not uniformly. However, the mechanisms underlying steatosis-induced progression of liver ca...
Prediction of Tumor Progression After Microwave Ablation of Hepatocellular Carcinoma by Contrast-Enhanced Ultrasound Combined with Immunohistochemical Markers [0.03%]
基于免疫组化标志物的声学造影超声预测肝癌微波消融后肿瘤进展的价值研究
Tian-Tian Dong,Ming Li,Yuan-Yuan Li et al.
Tian-Tian Dong et al.
Purpose: By integrating imaging data, laboratory markers, and the expression of immunohistochemical (IHC) markers, a mode l was developed to predict tumor progression (TP) following microwave ablation (MWA) in hepatocellu...
Noninvasive Prediction of High Ki-67 Expression in Hepatocellular Carcinoma Using Multiparametric MRI and Clinical Biomarkers [0.03%]
基于多参数MRI和临床生物标志物预测肝细胞癌高Ki-67表达的研究
Fan Zhang,Gen Chen,Mengqi Huang et al.
Fan Zhang et al.
Purpose: This study aimed to develop and validate a noninvasive multiparametric magnetic resonance imaging (MRI) model integrating hepatobiliary-phase T1 mapping (T1HBP), tumor-to-liver R2-star ratio (TLRR2*), and clinica...
Development of a Nomogram Model to Predict Post-Transplant Tumor Recurrence in Patients with Hepatocellular Carcinoma Beyond the Milan Criteria Undergoing TACE Bridging Therapy [0.03%]
发展用于预测米兰标准之外接受TACE过渡治疗的肝癌受者移植后肿瘤复发的列线图模型
Hao Wang,Encheng Liu,Mei Wu et al.
Hao Wang et al.
Objective: To develop a nomogram based on clinical characteristics for predicting post-transplant tumor recurrence in hepatocellular carcinoma (HCC) patients beyond the Milan criteria who received transarterial chemoembol...